Mesenchymal stem/stromal cells (MSCs) can regenerate tissues by direct differentiation or
indirectly by stimulating angiogenesis, limiting inflammation, and recruiting tissue-specific …

Cell-based therapy is a promising strategy for treating chronic kidney disease (CKD) and is
currently the focus of preclinical studies. We performed a systematic review and meta …

Introduction The apoptosis and subsequent injury of podocytes plays a pathogenic role in
diabetic nephropathy (DN). Mesenchymal stem cells (MSCs) are promising therapeutic cells …

We examined whether antagonism of the CXCR4 receptor ameliorates the loss of renal
function following ischemia-reperfusion. CXCR4 is ubiquitously expressed on leukocytes …

Injury to podocytes is an early event in diabetic nephropathy leading to proteinuria with
possible progression to end-stage renal failure. The podocytes are unique and highly …

Injury to a target organ can be sensed by bone marrow stem cells that migrate to the site of
damage, undergo differentiation, and promote structural and functional repair. This …

Renal damage resulting from acute and chronic kidney injury poses an important problem to
public health. Currently, patients with end-stage renal disease rely solely on kidney …

Background: During nephron induction, morphogenetic molecules are reciprocally
exchanged between epithelial and mesenchymal stem/progenitor cells within the renal …

Our previous study showed that in vivo magnetic resonance (MR) imaging is effective in
tracking superparamagnetic iron oxide (SPIO)‐labeled bone marrow mesenchymal stem …

A special feature of the renal stem/progenitor cell niche is its always close neighborhood to
the capsule during organ development. To explore this link, neonatal kidney was …